ATE112316T1 - Vom genom des papillomavirus-hpv-39 abgeleitete dns-sequenzen, deren anwendung in der in vitro- diagnose und zur herstellung einer immunogenenzusammensetzung. - Google Patents

Vom genom des papillomavirus-hpv-39 abgeleitete dns-sequenzen, deren anwendung in der in vitro- diagnose und zur herstellung einer immunogenenzusammensetzung.

Info

Publication number
ATE112316T1
ATE112316T1 AT92903034T AT92903034T ATE112316T1 AT E112316 T1 ATE112316 T1 AT E112316T1 AT 92903034 T AT92903034 T AT 92903034T AT 92903034 T AT92903034 T AT 92903034T AT E112316 T1 ATE112316 T1 AT E112316T1
Authority
AT
Austria
Prior art keywords
genome
dna sequences
sequences derived
production
application
Prior art date
Application number
AT92903034T
Other languages
German (de)
English (en)
Inventor
Gerard Orth
Christoph Volpers
Rolf E Streeck
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE112316T1 publication Critical patent/ATE112316T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT92903034T 1990-12-20 1991-12-20 Vom genom des papillomavirus-hpv-39 abgeleitete dns-sequenzen, deren anwendung in der in vitro- diagnose und zur herstellung einer immunogenenzusammensetzung. ATE112316T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9016044A FR2670797A1 (fr) 1990-12-20 1990-12-20 Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.

Publications (1)

Publication Number Publication Date
ATE112316T1 true ATE112316T1 (de) 1994-10-15

Family

ID=9403488

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92903034T ATE112316T1 (de) 1990-12-20 1991-12-20 Vom genom des papillomavirus-hpv-39 abgeleitete dns-sequenzen, deren anwendung in der in vitro- diagnose und zur herstellung einer immunogenenzusammensetzung.

Country Status (10)

Country Link
US (2) US5656423A (enExample)
EP (1) EP0563255B1 (enExample)
JP (1) JP3859696B2 (enExample)
AT (1) ATE112316T1 (enExample)
CA (2) CA2098819C (enExample)
DE (1) DE69104380T2 (enExample)
DK (1) DK0563255T3 (enExample)
ES (1) ES2062887T3 (enExample)
FR (1) FR2670797A1 (enExample)
WO (1) WO1992011369A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
AU1324000A (en) * 1998-10-26 2000-05-15 Ventana Medical Systems, Inc. Detection of human papilloma virus in papanicolaou (pap) smears
US7569344B2 (en) * 1998-10-26 2009-08-04 Ventana Medical Systems, Inc. Detection of human papilloma virus in papanicolaou (Pap) smears
CA2365901A1 (en) * 1999-04-14 2000-10-19 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
US20060275784A1 (en) * 1999-10-26 2006-12-07 Ventana Medical Systems, Inc. Detection of Human Papilloma Virus in Papanicolaou (Pap) Smears
US7312041B2 (en) * 2001-02-16 2007-12-25 Arbor Vita Corporation Methods of diagnosing cervical cancer
US20040229298A1 (en) * 2000-11-11 2004-11-18 Lu Peter S. Methods and compositions for treating cervical cancer
WO2003008649A1 (en) * 2001-07-20 2003-01-30 Board Of Regents, The University Of Texas System Methods and compositions relating to hpv-associated pre-cancerous and cancerous growths, including cin
EP1539245A2 (en) * 2002-06-26 2005-06-15 The Penn State Research Foundation Methods and materials for treating human papillomavirus infections
CN102023220A (zh) 2002-09-09 2011-04-20 生命树股份有限公司 诊断宫颈癌的方法
EP1664348B8 (en) 2003-09-25 2019-06-12 Third Wave Technologies, Inc. Detection of hpv
AU2004308964B2 (en) * 2003-12-23 2010-09-16 Arbor Vita Corporation Antibodies for oncogenic strains of HPV and methods of their use
US7354719B2 (en) 2004-12-08 2008-04-08 Gen-Probe Incorporated Detection of nucleic acids from multiple types of human papillomaviruses
JP4974899B2 (ja) * 2004-12-10 2012-07-11 ジェネラ バイオシステムズ リミテッド 組成物および検出方法
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US7732166B2 (en) * 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US20100003704A1 (en) 2008-06-13 2010-01-07 Shuling Cheng IN SITU detection of early stages and late stages HPV infection
NZ580242A (en) * 2007-04-05 2012-02-24 Genera Biosystems Ltd Compositions and methods of detection of hpv infection
GB0820822D0 (en) * 2008-11-13 2008-12-24 Inst Catala D Oncologia Novel product and processes
CN102449479B (zh) 2009-05-07 2015-11-25 安科健康公司 鉴别高度或≥cin2用于人乳头瘤病毒(hpv)与hpv相关癌症的早期及晚期检测、筛检和诊断
EP2521914A4 (en) 2010-01-08 2013-07-10 Oncohealth Corp CELL-BASED HPV IMMUNOTESTS HAVE A HIGH PERFORMANCE FOR DIAGNOSIS AND SCANNING OF HPV ASSOCIATED CANCER
AU2011258501B2 (en) * 2010-05-25 2016-07-07 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593828B2 (fr) * 1986-01-31 1990-05-04 Pasteur Institut Sonde a papillomavirus et procede de diagnostic in-vitro d'infections a papillomavirus
FR2629458B2 (fr) * 1987-07-31 1991-08-09 Ire Celltarg Sa Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain
US5447839A (en) * 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
US5182377A (en) * 1988-09-09 1993-01-26 Hoffmann-La Roche Inc. Probes for detection of human papillomavirus
FR2641081A1 (enExample) * 1988-12-23 1990-06-29 Medgenix Group

Also Published As

Publication number Publication date
JPH06504672A (ja) 1994-06-02
US5656423A (en) 1997-08-12
EP0563255A1 (fr) 1993-10-06
JP3859696B2 (ja) 2006-12-20
CA2098819C (fr) 2002-06-18
DE69104380T2 (de) 1995-02-09
CA2098819A1 (fr) 1992-06-21
US5665535A (en) 1997-09-09
FR2670797B1 (enExample) 1994-08-19
WO1992011369A1 (fr) 1992-07-09
DK0563255T3 (da) 1994-10-24
DE69104380D1 (de) 1994-11-03
CA2375673A1 (fr) 1992-07-09
ES2062887T3 (es) 1994-12-16
EP0563255B1 (fr) 1994-09-28
CA2375673C (fr) 2005-05-17
FR2670797A1 (fr) 1992-06-26

Similar Documents

Publication Publication Date Title
ATE112316T1 (de) Vom genom des papillomavirus-hpv-39 abgeleitete dns-sequenzen, deren anwendung in der in vitro- diagnose und zur herstellung einer immunogenenzusammensetzung.
ATE152779T1 (de) Verfahren zur diagnose des menschlichen papillome-viruses typ-16 durch ''polymerase chain reaction''
DE68922336D1 (de) Sonden für Papilloma-Virus (HPV49, HPV50, HPV54, HPV55), zu diesem Papilloma-Virus genetisch und immunologisch verwandte Produkte und in vitro Methoden zur Diagnose von Papilloma-Virusinfektionen und Herstellung von Antikörpern gegen diese Papilloma-Viren.
ATE552340T1 (de) Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismitteln
EP1394256A3 (en) HCV genomic sequences for diagnostics and therapeutics
ATE147752T1 (de) Oligothionukleotide
DE3682893D1 (de) Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen.
AU1342888A (en) Molecules comprising at least one peptidic sequence carrying one or a plurality of epitopes characterizing a protein produced by P.Falciparum in hepatocytes and compositions containing them
DK502389A (da) Pyridazinonderivater og fremgangsmaade til fremstilling deraf
ES2123000T3 (es) Secuencias de adn del papilomavirus hpv 42 y su aplicacion en diagnostico.
DE69028951D1 (de) Oligonukleotiden-Sequenzen zur Amplifizierung von HIV-2 und SIV Retrovirusgenomen, ihre Verwendung zur In-vitro-Diagnostik von durch diese Viren verursachten Infektionen
DE59808710D1 (de) Verfahren zur herstellung von 2-(3-pyrazolyl-oxymethylen)nitrobenzolen
DE60331758D1 (de) Neue vollständige genomische rna des japanenzephalitis-virus, infektiöse jev cdna daraus und deren verwendung
DE59008790D1 (de) Neisseria-spezifische DNA-Sonden.
DK0532566T3 (da) Cyklopentadienylcarbonyl-99mTc-komplekser, fremgangsmåde til fremstilling af disse samt deres anvendelse i diagnostikken
ATE527376T1 (de) Pna-sonden, sondensätze, verfahren und kits im zusammenhang mit dem nachweis von candida
FI98467B (fi) Ihmisen papilloomavirus tyyppi 57, sen eristetty DNA ja näiden käyttö
JPS5224913A (en) Ferritic stainless steel with excellent workability
ES2048652B1 (es) Procedimientos de amplificacion de genoma para la deteccion e identificacion de secuencias genomicas relacionadas.
EP1309342A4 (en) PREPARATION OF A CHIMERIC PAPILLOMA VIRUS (22.01.2)
DK0918754T3 (da) Anthranilsyrediamidderivater, fremstilling og farmaceutisk anvendelse deraf som antigastrinmidler
DE3764330D1 (de) 2,2;6,6-diethylen-3-oxo-17alpha-pregn-4-en-21, 17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharm. praeparate.
JPS5230715A (en) High chromium ferritic stainless steel
ATE104266T1 (de) 1-brom-3-chlor-1,2-diaryl-2-propanole, verfahren zur stereoselektiven herstellung der erythro-1- brom-3-chlor-1,2-diaryl-2-propanole und deren umsetzung zu azolylmethyloxiranen.
SHIRASUNA et al. Transforming ability of cytomegalovirus of an established cell line derived form human pleomorphic adenoma

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time